18.4 Leukocytes and Platelets

Leukocytes, or white blood cells, are the body's primary defense against infection and foreign invaders. Platelets are the cell fragments responsible for stopping bleeding when blood vessels are damaged. Together, these blood components form two critical arms of the body's protective system, and understanding their structure, function, and disorders is essential for grasping how blood works as a tissue.

Leukocytes

Characteristics and functions of leukocytes

White blood cells (WBCs) are the immune system's workhorses. Unlike red blood cells, which stay confined to blood vessels, leukocytes can squeeze through capillary walls and migrate into tissues where infection or inflammation is occurring. This ability is called diapedesis, and it's what allows WBCs to reach the actual site of a problem rather than just circulating past it.

All leukocytes originate in the bone marrow through hematopoiesis. Hematopoietic stem cells differentiate into specific WBC types depending on which cytokines and growth factors are present. From there, leukocytes split into two broad categories based on their microscopic appearance:

• Granulocytes (neutrophils, eosinophils, basophils) contain visible granules in their cytoplasm when stained. These granules hold enzymes and chemical mediators.
• Agranulocytes (lymphocytes, monocytes) lack prominent cytoplasmic granules.

Types of leukocytes in immune response

Each WBC type has a distinct appearance under the microscope and a specific job in immune defense. Knowing the relative percentages is useful for interpreting a differential WBC count, which is a common clinical lab test.

Neutrophils (50–70% of WBCs) The most abundant leukocyte and the first to arrive at an infection site. Neutrophils have a distinctive multilobed nucleus (typically 3–5 lobes) and fine, pale pink granules. Their primary function is phagocytosis, meaning they engulf and digest bacteria and fungi. Because they respond so quickly, neutrophils are often called the "first responders" of the immune system. They are short-lived, typically surviving only hours to a few days in tissues.

Eosinophils (2–4% of WBCs) Recognizable by their bilobed nucleus and large, coarse, reddish-orange granules. Eosinophils are especially important in defending against parasitic infections (such as helminth worms, which are too large for a single cell to phagocytose). They also play a role in allergic reactions by releasing enzymes that modulate inflammatory chemicals like histamine.

Basophils (0.5–1% of WBCs) The rarest granulocyte. Basophils have a lobed nucleus that's often obscured by their large, dark blue-purple granules. These granules contain histamine and heparin. When basophils degranulate during allergic reactions, the released histamine promotes vasodilation and increased capillary permeability, contributing to the inflammatory response.

Lymphocytes (25–35% of WBCs) Lymphocytes have a large, round nucleus surrounded by a thin rim of cytoplasm, making them easy to identify on a blood smear. They are the key players in specific (adaptive) immunity:

• T lymphocytes handle cell-mediated immunity, directly attacking infected or cancerous cells.
• B lymphocytes handle humoral immunity, producing antibodies that target specific antigens.
• Natural killer (NK) cells are a third type of lymphocyte that destroy virus-infected cells and tumor cells without needing prior antigen exposure.

Lymphocytes are unique because they can "remember" previously encountered pathogens, which is the basis for long-term immunity.

Monocytes (3–8% of WBCs) The largest leukocyte in circulation. Monocytes have a distinctive kidney-shaped (or horseshoe-shaped) nucleus and abundant pale-blue cytoplasm. On their own, monocytes are relatively inactive. Once they migrate into tissues, however, they differentiate into macrophages or dendritic cells. Macrophages are powerful phagocytes that engulf pathogens, dead cells, and debris. They also serve as antigen-presenting cells (APCs), displaying fragments of digested pathogens on their surface to alert T lymphocytes and initiate a targeted immune response.

Immune System and Inflammation

The immune system is a network of cells, tissues, and organs that work together to identify and eliminate threats. Leukocytes are the cellular component, but they rely on lymphoid organs (thymus, spleen, lymph nodes) and chemical signaling molecules (cytokines) to coordinate their responses.

Inflammation is one of the body's earliest protective responses to injury or infection. The four classic signs are redness, swelling, heat, and pain. These result from increased blood flow and capillary permeability at the injury site, which allows more leukocytes and plasma proteins to reach the damaged area. Inflammation is a nonspecific response, meaning it activates the same way regardless of the type of invader.

The bone marrow ties everything together: it's both the production site for all blood cells and the location where B lymphocytes mature. T lymphocytes, by contrast, mature in the thymus.

Platelets and Hemostasis

Structure and function of platelets

Platelets (thrombocytes) are small, disc-shaped cell fragments, not true cells. They form when large bone marrow cells called megakaryocytes shed pieces of their cytoplasm into the bloodstream. A single megakaryocyte can produce thousands of platelets. Platelets lack a nucleus but contain organelles, granules, and enzymes that are critical for clot formation. They circulate for about 8–10 days before being removed by the spleen.

The process of stopping bleeding is called hemostasis, and it occurs in three overlapping stages:

1. Vascular spasm — The damaged blood vessel immediately constricts, reducing blood flow to the area. This is triggered by direct injury to the smooth muscle in the vessel wall and by chemicals released from platelets and injured tissue.

2. Platelet plug formation — Platelets adhere to exposed collagen fibers in the damaged vessel wall (a process called platelet adhesion). Once attached, they become activated: they change shape from smooth discs to spiny spheres, and they release the contents of their granules (including ADP and thromboxane $A_2$). These chemicals recruit more platelets to the site, causing them to stick to each other (platelet aggregation) and form a temporary platelet plug.

3. Coagulation (blood clotting) — This is a complex cascade of reactions involving clotting factors (mostly proteins made by the liver). The cascade ultimately converts the soluble plasma protein fibrinogen into insoluble fibrin threads. These fibrin strands weave through the platelet plug, creating a reinforced mesh that stabilizes the clot. Activated platelets provide a phospholipid surface that is essential for assembling several of these clotting factors.

After the vessel heals, the clot is broken down through fibrinolysis, where the enzyme plasmin dissolves the fibrin mesh.

Disorders of leukocytes and platelets

Leukocyte disorders:

• Leukopenia — An abnormally low WBC count, which leaves the body vulnerable to infections. Common causes include certain medications (especially chemotherapy drugs), autoimmune disorders, and bone marrow failure.
• Leukocytosis — An elevated WBC count. This is often a normal response to infection or inflammation, but it can also result from stress, smoking, or corticosteroid use. A persistently elevated count without an obvious cause warrants further investigation.
• Leukemia — A cancer of the blood-forming tissues in which the bone marrow produces large numbers of abnormal, nonfunctional leukocytes. These crowd out normal blood cells, leading to anemia (from reduced RBCs), increased infections (from dysfunctional WBCs), and bleeding problems (from reduced platelets).

Platelet disorders:

• Thrombocytopenia — A low platelet count (below approximately 150,000 per $\mu L$), which increases the risk of excessive bleeding. Causes include autoimmune destruction of platelets, certain medications, and bone marrow disorders.
• Thrombocytosis — An elevated platelet count, which raises the risk of inappropriate clot formation (thrombosis). It can be triggered by chronic inflammation, iron deficiency, or certain cancers.
• Platelet dysfunction — Platelets are present in normal numbers but don't function properly, leading to prolonged bleeding time. This can be inherited (as in von Willebrand disease) or acquired. A common acquired cause is medication use: aspirin irreversibly inhibits thromboxane $A_2$ production, which impairs platelet aggregation for the entire lifespan of the affected platelet (about 8–10 days).